Former FDA Commissioner or Wife Held Stock in FDA Regulated Area – NYT Thu, 27 Oct 2005 The mystery behind the resignation of Dr. Lester Crawford seems to be about failure to divest from financail holdings in companies regualted by the FDA. The New York Times cites Dr. Crawford’s statement to Forbes last month, “saying that he had…
An Epidemic of Overreaction /The scare Scenario / The Fear Epidemic Thu, 27 Oct 2005 Dr. Marc Siegel, a practicing internist and an associate professor of medicine at New York University School of Medicine, and a subscriber to the AHRP Infomails, forwarded 3 recent Op Ed articles he has published–in The Nation, the Los Angeles…
Scientific American: Preparing for a Pandemic Wed, 26 Oct 2005 An article in Scientific American (excerpt below) provides a totally different explanation of a pandemic influenza outbreak than that offered in reports sent in yesterday’s Infomail. Two sites have been highly recommended for reliable information: FLU WIKI: http://www.fluwikie.com/ and EFFECT MEASURE: http://effectmeasure.blogspot.com/ Contact: Vera Hassner…
NYT reporter Judith Miller: Woman of Mass Destruction–Not Joan of Arc Sat, 22 Oct 2005 New York Times columnist, Maureen Dowd: “Investigative reporting is not stenography.” Judith Miller”s reputation has taken a sprialling spin downward from her own doing–she transcribed what her Administration “sources” and their conmen fed her- Unfortunately, Judith Miller is not the…
States Protest Contributions to Drug Plan – New York Times Tue, 18 Oct 2005 The New York Times reports: “On Monday, the administration unveiled a new online tool to help Medicare beneficiaries choose a prescription plan from the dozens of plans available in each state. But some of the information was not yet available from…
October 14, 2005 link to pdf of original letter Dr. Russell Katz Director, Neuropharmacological Drug Products Food and Drug Administration, FDA 120 1451 Rockville Pike, Room 4037 Rockville, MD 20852 Re: FDA Neurontin Safety Analyses Dear Dr. Katz: Due to the continued public danger facing a substantial class of prescription drug users, I am…
Bush’s Choice for F.D.A. Chief to Keep Other Job Mon, 26 Sep 2005 President Bush proposes to appoint Dr. von Eschenbach to head the FDA while at the same time maintaining his “day job” as head of the National Cancer Institute. Clearly the administration thinks very little about the importance of FDA’s role as watchdog…
FDA Had Report of Heart Device failures Mon, 12 Sep 2005 A series of irresponsible national policies put corporate interests above public safety undermining the health and lives of American citizens. The world witnessed the consequences of those irresponsible policies: namely, a colossal break down in the nation’s homeland security aparatus which had been rendered…
Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ Mon, 12 Sep 2005 Abbott Laboratories is asking the FDA to approve a cancer drug even though it failed in clinical trials to demonstrate a benefit greater than placebo–which is a minimal FDA requirement. The Wall Street Journal reports: “Xinlay is central to…
Testimony by Vera Hassner Sharav, President ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Hearing of the NYS Assembly Committee on Health and Committee on Children and Families September 8, 2005 New York City I speak on behalf of the ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP), the organization that filed the federal complaint about the enrollment…
EPA Declines to Show Proposed Regulations for Human Pesticide Experiments Wed, 7 Sep 2005 When the committee of the Institute of Medicine gave the pesticide industry and the EPA the green light to accept data from human pesticide experiments, it opened the door for government-sanctioned experimental abuse that surpasses the CIA-sponsored LSD and electroshock experiments….
Olive Oil Better than Anti-Inflammatory Drugs Tue, 6 Sep 2005 Amidst the disaster, one ray of good news for universal good health! This news was burried in a side bar of the Science section of The New York Times. Contact: Vera Hassner Sharav 212-595-8974 The New York Times September 6, 2005 Heart Health: Scientists Shed…
